Aruna Sharma

Dr. Aruna Sharma

Department of Surgical Sciences, Akademiska Sjukhuset, Uppsala University, Uppsala, Sweden

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2016 in CNS & Neurological Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
ASAruna Sharma
Aruna Sharma
PMPreeti Menon
Preeti Menon
DMDafin F. Muresanu
Dafin F. Muresanu
AOAsya Ozkizilcik
Asya Ozkizilcik
RTRyan Tian
Ryan Tian
HSHari S. Sharma
Hari S. Sharma
The blood-brain barrier (BBB) is a physiological regulator of transport of essential items from blood to brain for the maintenance of homeostasis of the central nervous system (CNS) within narrow limits. The BBB is also responsible for export of harmful or metabolic products from brain to blood to keep the CNS fluid microenvironment healthy. However, noxious insults to the brain caused by trauma, ischemia or environmental/chemical toxins alter the BBB function to small as well as large molecules e.g., proteins. When proteins enter the CNS fluid microenvironment, development of brain edema occurs due to altered osmotic balance between blood and brain. On the other hand, almost all neurodegenerative diseases and traumatic insults to the CNS and subsequent BBB dysfunction lead to edema formation and cell injury. To treat these brain disorders suitable drug therapy reaching their brain targets is needed. However, due to edema formation or only a focal disruption of the BBB e.g., around brain tumors, many drugs are unable to reach their CNS targets in sufficient quantity. This results in poor therapeutic outcome. Thus, new technology such as nanodelivery is needed for drugs to reach their CNS targets and be effective. In this review, use of nanowires as a possible novel tool to enhance drug delivery into the CNS in various disease models is discussed based on our investigations. These data show that nanowired delivery of drugs may have superior neuroprotective ability to treat several CNS diseases effectively indicating their role in future therapeutic strategies.

1 January 2020
Verified
Book Chapter
Closed access
PDF file
Hari SharmaHari Sharma
Hari Sharma
DMDafin F. Muresanu
Dafin F. Muresanu
RCRudy J. Castellani
Rudy J. Castellani
Ala NozariAla Nozari
Ala Nozari
JLJosé Vicente Lafuente
José Vicente Lafuente
ASAruna Sharma
Aruna Sharma


1 January 2021
Verified
Book Chapter
Closed access
ASAruna Sharma
Aruna Sharma
LFLianyuan Feng
Lianyuan Feng
DMDafin F Muresanu
Dafin F Muresanu
SSSeaab Sahib
Seaab Sahib
ZTZ Ryan Tian
Z Ryan Tian
Hari SharmaHari Sharma
Hari Sharma

1 January 2021
Verified
Book Chapter
Closed access
ASAruna Sharma
Aruna Sharma
DMDafin F. Muresanu
Dafin F. Muresanu
RPRanjana Patnaik
Ranjana Patnaik
PMPreeti K. Menon
Preeti K. Menon
ZTZ. Ryan Tian
Z. Ryan Tian
Hari SharmaHari Sharma
Hari Sharma

1 January 2020
Verified
Book Chapter
Closed access
ASAruna Sharma
Aruna Sharma
DMDafin F. Muresanu
Dafin F. Muresanu
RCRudy J. Castellani
Rudy J. Castellani
Ala NozariAla Nozari
Ala Nozari
JLJosé Vicente Lafuente
José Vicente Lafuente
Hari SharmaHari Sharma
Hari Sharma